跳至主要内容
临床试验/IRCT20230801058997N1
IRCT20230801058997N1已完成3 期

Investigation of the Keloid treatment results using plasma device combined with or without triamcinolone injection

Islamic Azad University0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • The minimum age is 18 and the maximum age is 70 years
  • Informed consent to participate in the study
  • People who have the possibility of follow-up after treatment
  • People who have a keloid scar with a maximum height of 5 mm

排除标准

  • Pregnant or lactating patients and children under 15 years old due to the possible side effects of triamcinolone
  • People who have had a history of treatment at the site of the lesion in the last 6 months
  • People who have any type of underlying disease that affects wound healing

研究者

相似试验